Skip to content

诺万达公司

US · NOVT #1995 按市值排名 上市于 1970
128.79 -6.01 -4.46%
实时 - 追踪5344个代码 - 心跳于139秒前 · 2026-10-16 19:30

✦ 量化财务健康度 计算方式说明

良好
  • 奥特曼 Z 值为7.31,高于3.0的"安全区"阈值。
  • 该模型对工业和制造业公司最为可靠,对银行、保险等金融类公司参考意义较弱。

营收 年度数据,近8年

最近年度同比+3.30%

利润率

毛利率
44.39%
营业利润率
11.90%
净利率
5.49%

关键比率与质量指标

奥特曼 Z 值低于约1.8提示财务困境风险,高于约3.0提示风险较低;该模型对工业和制造业公司最为可靠,对银行等金融类公司参考意义较弱。

利润表

项目 2018 2019 2020 2021 2022 2023 2024 2025
营收 614.34M626.10M590.62M706.79M860.90M881.66M949.25M980.60M
毛利润 261.53M262.09M244.52M300.33M378.47M399.90M421.55M435.28M
销售及管理费用 115.90M118.41M109.85M129.16M158.90M164.46M175.94M195.66M
研发费用 51.02M55.97M61.00M72.52M85.77M91.68M95.52M95.48M
营业利润 79.05M71.86M59.70M82.07M107.46M123.31M124.29M116.66M
税前利润 61.30M45.77M48.40M56.17M87.16M83.75M79.07M69.64M
税费 10.21M4.99M3.88M5.84M13.11M10.87M14.98M15.81M
净利润 51.10M40.77M44.52M50.33M74.05M72.88M64.09M53.83M
基本每股收益 11112221
稀释每股收益 1.431.151.251.412.062.021.771.47

资产负债表

项目 2018 2019 2020 2021 2022 2023 2024 2025
流动资产总额 281.77M304.51M304.17M373.83M420.52M415.30M433.65M782.60M
现金及短期投资 82.04M78.94M125.05M117.39M100.11M105.05M113.99M380.87M
存货 104.76M116.62M92.74M125.66M168.00M149.37M144.61M188.28M
总资产 719.58M869.74M865.18M1.23B1.24B1.23B1.39B1.81B
流动负债总额 104.20M134.85M114.23M183.94M164.52M139.18M167.79M212.37M
短期负债 4.54M11.38M21.42M13.03M13.26M13.88M14.57M48.15M
长期负债 202.84M215.33M194.93M429.36M430.66M349.40M411.95M212.54M
总负债 351,321,000.00452,564,000.00388,370,000.00706,592,000.00663,626,000.00552,596,000.00642,813,000.00492,819,000.00
股东权益总额 368.26M417.17M476.81M521.29M577.59M673.46M745.70M1.31B
留存收益 -79.09M-38.32M6.20M56.53M130.58M203.46M267.55M321.38M

现金流量表

项目 2018 2019 2020 2021 2022 2023 2024 2025
经营活动现金流 89.65M63.25M140.24M94.63M90.78M120.08M158.51M64.06M
折旧与摊销 37.05M38.28M38.29M43.39M53.16M46.61M55.56M61.93M
自由现金流 74.99M52.51M127.08M72.45M69.67M100.11M141.35M48.43M
已派股息 ----------------
股票回购/发行 -5.85M-10.00M-5.50M0-10.00M00575.11M
期末现金余额 82.04M78.94M125.05M117.39M100.11M105.05M113.99M380.87M

回报与效率指标

项目 2018 2019 2020 2021 2022 2023 2024 2025
净资产收益率 14.9710.389.9610.0913.4811.659.035.23
总资产收益率 7.045.135.134.816.005.914.903.37
投入资本回报率 9.016.446.265.767.116.805.593.80
5年平均净资产收益率 8.5212.7411.6011.8711.7811.1110.849.89
息税前利润率 12.8711.4810.1111.6112.4813.9913.0911.90
自由现金流/营收 12.218.3921.5210.258.0911.3614.894.94
流动比率 2.702.262.662.032.562.982.583.69
速动比率 1.611.301.781.281.451.811.632.71
资产负债率 29.8331.7029.4840.1839.4333.0033.8716.71
长期负债权益比 57.0663.3549.0092.1582.4358.0161.1119.31
利息保障倍数 ----------------
营收复合年增长率(3年) 18.0317.624.254.7811.2014.2910.334.44
净利润复合年增长率(3年) 11.3022.83-9.490.8222.0117.858.39-10.09
自由现金流复合年增长率(3年) 39.1010.1132.78-1.149.89-7.6424.96-11.41

✦ 量化营收集中度 计算方式说明

主业突出,长尾分散
  • 在披露的2个业务分部中,Automation Enabling Technologies是最大的一项,占营收的51.25%。
  • 紧随其后的Medical Solutions占比48.75%,说明主业仍最重要,但并非全部。

营收构成 最近报告期

业务分部

Automation Enabling Technologies51.25%
Medical Solutions48.75%

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

诺万达公司 讨论区 0 条评论

发表评论